Načítá se...

Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9

Clustered regularly interspaced short palindromic repeat (CRISPR) RNAs and their associated effector (Cas) enzymes are being developed into promising therapeutics to treat disease. However, CRISPR-Cas enzymes might produce unwanted gene editing or dangerous side effects. Drug-like molecules that can...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nucleic Acid Ther
Hlavní autoři: Barkau, Christopher L., O'Reilly, Daniel, Rohilla, Kushal J., Damha, Masad J., Gagnon, Keith T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc., publishers 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6555185/
https://ncbi.nlm.nih.gov/pubmed/30990769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0758
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!